Pregabalin-Induced Edema

Mechanism and Prevalence

Pregabalin binds to the α-2-δ subunit of calcium channels, which may contribute to fluid retention and subsequent edema, as reported by the American Diabetes Association 1, 2
When used as monotherapy, peripheral edema occurs in approximately 3-5% of patients taking pregabalin, according to the American Heart Association 3

The edema is dose-dependent, with higher doses associated with increased risk, as noted by the American Diabetes Association 1, 2
Risk factors for developing pregabalin-induced edema include higher doses of pregabalin, as reported by the American Diabetes Association 2
Concomitant use with other medications that cause fluid retention is also a risk factor, as stated by the American Heart Association 3

Dose reduction may be considered if edema develops, as suggested by the American Diabetes Association 2

Duloxetine (60-120 mg/day) has shown efficacy for diabetic neuropathic pain without causing edema, according to the American Diabetes Association 4
Topical agents such as lidocaine patches may provide localized pain relief without systemic side effects, as reported by the American Diabetes Association 2

The edema generally begins shortly after initiation of therapy and persists in a significant proportion of patients until discontinuation, according to the Mayo Clinic Proceedings 5
Gabapentin, while structurally similar to pregabalin, may also cause edema, though potentially at lower rates, as noted in the Mayo Clinic Proceedings 5
Peripheral edema from pregabalin may counteract benefits from topical medications used for conditions like erythromelalgia, making it a particularly poor choice in such scenarios, as reported in the Mayo Clinic Proceedings 5